findmyKOL

Tochukwu Okwuosa, DO

Basic profile

Rush University Medical Center

ORCIDNone on fileNPI
RegionChicago, IL · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH funding2021–2021Why? →

Tochukwu Okwuosa is a Cardiology physician affiliated with Rush University Medical Center. OpenAlex indexes 73 publications with 2,330 citations (h-index 20).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
73publications

Distinct works indexed by OpenAlex.

2,330citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2021–2021

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1725 W Harrison St
Suite 1010
Chicago, IL 606123841

Telephone

312-942-6253

Registry record last updated 25 Mar 2014.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    84.2%
    Statin21.7%
    Rosuvastatin Calcium71%Atorvastatin Calcium23%Pravastatin Sodium7%
    Part D245 patients
    Beta blocker20.5%
    Metoprolol Succinate45%Carvedilol43%Nebivolol Hcl11%Metoprolol Tartrate2%
    Part D<11 patients

    + 16 more classes in this area

  • Blood & clotting

    7.6%
    Factor Xa inhibitor6.1%
    Eliquis82%Xarelto18%
    Part D67 patients
    P2Y12 inhibitor1.1%
    Clopidogrel100%
    Part D19 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    7.4%
    SGLT2 inhibitor4.9%
    Jardiance94%Farxiga6%
    Part D<11 patients
    Potassium supplement2.4%
    Potassium Chloride73%Klor-Con M2027%
    Part D28 patients
Where care is delivered (Part B)75.1% facility · 24.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20212021 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”